New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 25, 2013
14:04 EDTCNATConatus Pharmaceuticals emricasan designated for orphan status
Conatus Pharmaceuticals' emricasan received FDA orphan designation for the treatment of liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end stage liver disease. Reference Link
News For CNAT From The Last 14 Days
Check below for free stories on CNAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CNAT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use